MedPath

Acupuncture in Low Anterior Resection Syndrome Treatment

Phase 1
Completed
Conditions
Low Anterior Resection Syndrome
Registration Number
NCT03916549
Lead Sponsor
National Cancer Institute, Lithuania
Brief Summary

Acupuncture has it's role in treating patients with fecal incontinence and diarrhea-predominant irritable bowel syndrome. There is no trial or case-report assessing it's role in treatment of Low anterior resection syndrome.

Detailed Description

Colorectal cancer is common in Western countries. For thirty years rectal cancer treatment is standardized: patients are undergoing low anterior resection with mesorectal excision +/- (chemo)radiotherapy. Unfortunately around 80% of patients undergoing low anterior resection will experience complex bowel dysfunction including fecal incontinence, soiling, urgency, incomplete evacuation, fragmented defecation and impaired rectal sensation known as low anterior resection syndrome (LARS) causing a "toilet dependence" which severely affects quality of life.

Still there is no standardized treatment for LARS.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • patients over 18 year
  • signed written consent
  • patients experiencing major low anterior resection syndrome
  • patients at least one year following the surgery
Exclusion Criteria
  • allergy to stainless steal
  • implanted pacemaker
  • current skin infection
  • needle phobia
  • metastatic disease to the central nervous system (brain, spinal cord)
  • at the same time, application of smecta, dicetel, cisapride or traditional Chinese medicine;

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Bowel function changes after the treatment using Low anterior resection syndrome questionnaire6 months

Bowel function assessment using Low anterior resection syndrome questionnaire Bowel function following low anterior resection surgery for rectal cancer will be assessed using Low anterior resection syndrome score (LARS score - simple 5 question questionnaire). LARS score is a tool consisting of five items, which are as follows: incontinence due to flatus (score range from 0 to 7), incontinence due to liquid stools (score range from 0 to 3), frequency of bowel movements (score range from 0 to 5), clustering (score range from 0 to 11) and urgency (score range from 0 to 16). The severity of each item is calculated on a scale ranging from 0 to 42, with a score of 0-20 (no LARS), 21-29 (minor LARS) and 30-42 (major LARS).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Cancer Institute

🇱🇹

Vilnius, Lithuania

National Cancer Institute
🇱🇹Vilnius, Lithuania

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.